Thursday, June 26, 2014

Stratos Genomics Gets Strategic Investment From Roche

Seattle-based Stratos Genomics has received a strategic investment from Roche, the two announced today, to support the development of Stratos' DNA sequencing technology. Size of the investment was not announced. Stratos is led by Allan Stephan. The company said the investment will help support its research team, and advance its work on "nanopore sequencing", a single molecule detection process for DNA sequencing. A recently regulatory filing by Stratos Genomics indicates that the firm recently raised $10M out of an ongoing $16.3M funding round from a single investor--presumably, Roche--but the company has not confirmed those details. More information »